Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF for Atrophic Acne Scars
NCT07094958Not yet recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2025
- Primary completion
- Dec 2025
- Modality
- Stem Cell Therapies
01
Overview
Randomised, double-blind trial of autologous adipose stromal vascular fraction in atrophic acne scars (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Change in total number of atrophic acne scars from baseline at 10 weeks. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
atrophic acne scars
Beyond the preview
Go deeper on NCT07094958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07094958.